Your session is about to expire
← Back to Search
Antiretroviral
Intervention Recipients for Behavioral Mechanisms
N/A
Waitlist Available
Led By Sybil Hosek, PhD
Research Sponsored by Hektoen Institute for Medical Research
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 48 weeks
Awards & highlights
Study Summary
This trial will study the safety of pre-exposure prophylaxis (PrEP) for transgender youth.
Eligible Conditions
- Behavioral Mechanisms
- Gender
- HIV/AIDS
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 48 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~48 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
PrEP Acceptability Questionnaire
Tenofovir diphosphate levels
Trial Design
1Treatment groups
Experimental Treatment
Group I: Intervention RecipientsExperimental Treatment1 Intervention
PrEP Demonstration Project intervention will be given
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
PrEP Demonstration Project
2022
N/A
~60
Find a Location
Who is running the clinical trial?
National Institute of Mental Health (NIMH)NIH
2,785 Previous Clinical Trials
2,689,705 Total Patients Enrolled
Hektoen Institute for Medical ResearchLead Sponsor
8 Previous Clinical Trials
7,681 Total Patients Enrolled
Sybil Hosek, PhDPrincipal InvestigatorCook County Health
10 Previous Clinical Trials
768 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger